Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC

Gastric cancer is the fourth leading cause of cancer deaths worldwide. Most patients are diagnosed in the advanced stage. Inadequate therapeutic strategies and the high recurrence rate lead to the poor 5-year survival rate. Therefore, effective chemopreventive drugs for gastric cancer are urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mingzhu, Duan, Lina, Wu, Wenjie, Li, Wenjing, Zhao, Lili, Li, Ang, Lu, Xuebo, He, Xinyu, Dong, Zigang, Liu, Kangdong, Jiang, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163056/
https://www.ncbi.nlm.nih.gov/pubmed/37147297
http://dx.doi.org/10.1038/s41389-023-00472-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163056/
https://www.ncbi.nlm.nih.gov/pubmed/37147297
http://dx.doi.org/10.1038/s41389-023-00472-4

Ejemplares similares